A study of ADXS-NEO for the treatment of cancer
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2017
At a glance
- Drugs ADXS NEO (Primary)
- Indications Cancer; Solid tumours
- Focus Adverse reactions; First in man
- 13 Jun 2017 According to an Advaxis media release, the FDA has accepted the ADXS-NEO IND in March 2017.
- 12 Aug 2016 New trial record
- 02 Aug 2016 According to an Advaxis media release, clinical trials are expected to begin in the year 2017.